Literature DB >> 14967775

Peripheral nerve involvement in spinocerebellar ataxias.

Bart P C van de Warrenburg1, Nicolette C Notermans, Helenius J Schelhaas, Nens van Alfen, Richard J Sinke, Nine V A M Knoers, Machiel J Zwarts, Berry P H Kremer.   

Abstract

BACKGROUND: In autosomal dominant cerebellar ataxias (ADCAs), it is unclear whether the associated peripheral nerve involvement is always a typical length-dependent axonopathy rather than primary neuronopathy due to neuronal degeneration in the spinal anterior horns and/or dorsal root ganglia.
OBJECTIVE: To study the nature and extent of peripheral nerve involvement in patients with ADCA. PATIENTS AND METHODS: Standardized clinical and electrophysiologic studies of 27 genotyped patients with ADCA were conducted prospectively, with special emphasis on the distinction between primary neuronopathy and dying-back axonopathy.
RESULTS: Electrophysiologic evidence of involvement of the peripheral nervous system was present in 70% of patients. Findings were compatible with dying-back axonopathy in 30%, while in 40% of patients, neuronopathy was diagnosed. Patients with spinocerebellar ataxia (SCA) 1 and SCA2 mostly displayed features of neuronopathy, while patients with SCA3 and SCA7 displayed both neuronopathy and axonopathy. In SCA6, no significant peripheral nerve involvement was demonstrated. We did not observe an influence of age, disease duration, or ataxia severity on the presence or type of peripheral nerve involvement.
CONCLUSIONS: Peripheral nerve involvement in ADCA manifests not only as distal axonal neuropathy, but also as primary neuronopathy. Electrodiagnostic studies in this group of patients should be conducted in such a way that primary neuronopathy is detected.

Entities:  

Mesh:

Year:  2004        PMID: 14967775     DOI: 10.1001/archneur.61.2.257

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  22 in total

Review 1.  Clinical, psychological, and genetic characteristics of spinocerebellar ataxia type 19 (SCA19).

Authors:  H Jurgen Schelhaas; Bart P C van de Warrenburg
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

2.  Peripheral neuropathy in chromosome16q22.1 linked autosomal dominant cerebellar ataxia.

Authors:  Yoshiko Furiya; Makito Hirano; Masami Nomura; Hirohide Asai; Takao Kiriyama; Satoshi Ueno
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09       Impact factor: 10.154

Review 3.  Consensus Paper: Neurophysiological Assessments of Ataxias in Daily Practice.

Authors:  W Ilg; M Branscheidt; A Butala; P Celnik; L de Paola; F B Horak; L Schöls; H A G Teive; A P Vogel; D S Zee; D Timmann
Journal:  Cerebellum       Date:  2018-10       Impact factor: 3.847

4.  Peripheral neuropathy in chromosome16q22.1 linked autosomal dominant cerebellar ataxia.

Authors:  Yoshiko Furiya; Makito Hirano; Masami Nomura; Hidehiro Asai; Takao Kiriyama; Satoshi Ueno
Journal:  BMJ Case Rep       Date:  2009-02-02

5.  Peripheral Neuropathy in Spinocerebellar Ataxia Type 1, 2, 3, and 6.

Authors:  Christoph Linnemann; Sophie Tezenas du Montcel; Maryla Rakowicz; Tanja Schmitz-Hübsch; Sandra Szymanski; Jose Berciano; Bart P van de Warrenburg; Karine Pedersen; Chantal Depondt; Rafal Rola; Thomas Klockgether; Antonio García; Gurkan Mutlu; Ludger Schöls
Journal:  Cerebellum       Date:  2016-04       Impact factor: 3.847

6.  Reduced cardiac 123I-metaiodobenzylguanidine uptake in patients with spinocerebellar ataxia type 2: a comparative study with Parkinson's disease.

Authors:  Anna De Rosa; Sabina Pappatà; Teresa Pellegrino; Maria Fulvia De Leva; Gennaro Maddaluno; Giovanni Fiumara; Raffaella Carotenuto; Mario Petretta; Alessandro Filla; Giuseppe De Michele; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-09       Impact factor: 9.236

7.  Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument.

Authors:  H Jacobi; M Rakowicz; R Rola; R Fancellu; C Mariotti; P Charles; A Dürr; M Küper; D Timmann; C Linnemann; L Schöls; O Kaut; C Schaub; A Filla; L Baliko; B Melegh; J-S Kang; P Giunti; B P C van de Warrenburg; R Fimmers; T Klockgether
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

Review 8.  Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.

Authors:  Antoni Matilla-Dueñas; Ivelisse Sánchez; Marc Corral-Juan; Antoni Dávalos; Ramiro Alvarez; Pilar Latorre
Journal:  Cerebellum       Date:  2010-06       Impact factor: 3.847

Review 9.  Spinocerebellar ataxia 2 (SCA2).

Authors:  Isabel Lastres-Becker; Udo Rüb; Georg Auburger
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

10.  Electrophysiology in spinocerebellar ataxias: spread of disease and characteristic findings.

Authors:  Ludger Schöls; Christoph Linnemann; Christoph Globas
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.